GSK199 analog (hydrochloride)

GSK199 analog (hydrochloride)

• CAS Number: 2048226-46-4
• UNSPSC Description: GSK199 analog hydrochloride belongs to a class of compounds that inhibit PAD4 (guanidinoarginine deiminase 4). GSK199 analog hydrochloride has potential uses in diseases including rheumatoid arthritis, vasculitis, systemic lupus erythematosus, ulcerative colitis, cancer, cystic fibrosis, asthma, cutaneous lupus erythematosus, and psoriasis[1].
• Target Antigen: Protein Arginine Deiminase
• Type: Reference compound
• Related Pathways: Epigenetics
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/gsk199-analog-hydrochloride.html
• Smiles: O=C(N1C[C@H](N)CCC1)C2=CC(OC)=C3C(N=C(C(N4CC)=CC5=C4C=CC=C5)N3C)=C2.Cl
• Molecular Weight: 467.99
• References & Citations: [1]Benzoimidazole derivatives as pad4 inhibitors. WO2016185279 A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported